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Purpose: The development of parallel MRI has resulted in the frequent use 
of diffusion-weighted imaging (DWI) in clinical medicine, and it usually 
involves the use of contrast medium. However, the gadolinium (Gd) 
contrast medium may have some effect on DWI and the apparent diffusion 
coefficient (ADC). The present study was performed to determine whether 
the magnetic susceptibility of contrast medium alters the DWI signal and 
the value of ADC in some imaging techniques. 
Materials and Methods: Non-fat suppression DWI, STIR combination 
and CHESS combination DWI were performed to examine 10 phantoms 
with Gd-DTPA dissolved at concentrations from 0.0005 to 0.1 mmol in 
physiological saline as contrast medium. The average pixel value and ADC 
of each method were determined. 
Results: ADC showed no differences between before and after treatment 
with contrast medium for all imaging techniques with Gd considered to be 
distributed over the whole tumour. The signal intensity did not change on 
non-fat suppression or CHESS combination DWI but deteriorated on STIR. 
Therefore, ADC was not influenced by the magnetic susceptibility of 
contrast medium. In addition, it was suggested that the ability of tumour 
detection may be reduced if STIR is used as fat suppression.  
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   Diffusion-weighted imaging (DWI) has contributed to diagnosis as a 
new compliment to MRI. In particular, it has become the most important 
imaging technique in the diagnosis of acute stroke. With the recent 
development of parallel MRI, DWI has often been used in clinical 
medicine to both search for tumours and for discrimination diagnosis 
(1–13). 
   However, the application of DWI in routine clinical examinations has 
not been established. Therefore, DWI is often performed after use of 
contrast medium. Therefore, there is concern regarding whether gadolinium 
(Gd) contrast medium influences the DWI signal and the value of the 
apparent diffusion coefficient (ADC). 
There are two major concerns regarding the possible effects of Gd contrast 
medium on DWI and ADC. 
 1. Effects on ADC due to the shrinkage of blood vessels and changes in 
blood viscosity by contrast medium. 
 2. Effects on DWI and ADC due to the magnetic susceptibility of the 
contrast medium. 
 
There have been a number of reports regarding the effects on ADC due to 
the shrinkage of blood vessels and changes in blood viscosity caused by 
contrast medium (14–17). However, these studies in both mice and humans 
examined the effects on ADC of blood vessel shrinkage and changes in 
blood viscosity due to contrast medium as well as those caused by 
magnetic susceptibility of contrast medium together. In the present study, 
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we treated these effects separately. 
The present study was performed to determine whether the magnetic 
susceptibility of contrast medium alters the signal of DWI and the value of 
ADC. 
 
Materials and Methods 
A 1.5T superconducting scanner unit (Magnetom Symphony; Siemens, 
Erlangen, Germany) with high-sensitivity quadrature-coils was used. The 
study design and review of patient records and images were approved by 
our institutional review board. 
First, we examined the amount of contrast medium distributed over the 
tumour following administration at a concentration of 0.1 mmol/kg body 
weight in human subjects by comparing the signal intensity after with that 
before contrast enhancement. We compared pixel values of the ROI in the 
tumour mass with T1 weighted (TR650 ms,TE17 ms) images before and 
after contrast enhancement in 20 meningiomas and 20 brain metastatic 
lesions which were homogeneous and high-enhancement. In addition, each 
signal value was measured in fifteen phantoms obtained with Gd contrast 
medium with the concentration increased to 0.01 mmol from in 
physiological saline using the above scanning factor. 
The quantities of Gd distribution in brain tumours before and after contrast 
enhancement were estimated from the relation between the Gd contrast 
medium content and signal value. 
  Next, to review the effects of Gd contrast medium on DWI, ten 
phantoms were subjected to non-fat suppression DWI, STIR combination 
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DWI and CHESS combination DWI in b=0, 500, 1000 x 10-3 s/mm2 in 
motion-probing gradient (MPG). The ten phantoms with Gd-DTPA at 
concentrations from 0.0005 to 0.1 mmol in physiological saline were 
supported in a water tank. The scanning parameters were EPI (TR1000 ms, 
TE50 ms, slice thickness 5 mm, 128×128 matrix). The arrangement 
position of phantoms was changed twice to avoid position-dependent 
artefacts and image non-uniformity. In addition, these images were scanned 
four times at each position. T1-weighted images and DWI of these 
phantoms are shown in Fig. 1. The average pixel values of each phantom of 
b=1000 x 10-3 s/mm2 of ten images were measured. In addition, ADC was 
calculated for three points: b=0, 500, 1000 x 10-3 s/mm2. 
 
Results 
  In meningioma and metastatic tumours in the brain, the quantity of 
distribution of Gd contrast medium was estimated based on the increases in 
pixel values after contrast enhancement. The quantitative Gd distributions 
before and after contrast enhancement of 20 meningiomas and 20 
metastatic brain tumours are shown in Fig. 2. Based on the results in 40 
tumours shown in Fig. 2, the quantity of Gd contrast medium distributed in 
tumours was estimated with contrast medium at concentrations ranging 
from 0.001–0.005 mmol. 
The ten phantom images with contrast medium consisting of Gd in 
physiological saline at concentrations of 0.0005–0.1 mmol were subjected 
to DWI non-fat suppression, STIR combination DWI and CHESS 
combination DWI in b=1000 x 10-3 s/mm2 in MPG. The pixel values of 
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phantom images are shown in Fig. 3. Both non-fat suppression DWI and 
CHESS combination DWI showed similar signal intensities for Gd density. 
In addition, no changes were observed in signal value up to a Gd 
concentration of 0.005 mmol, but tended to decrease at concentrations 
above this level. The signal value was generally lower for STIR 
combination DWI than for other imaging techniques and decreased with 
increases in Gd concentration. The contrast medium density distribution in 
the tumour is surrounded with a solid line on this graph. For non-fat 
suppression DWI and CHESS combination DWI, only tumours in which 
the contrast effect was very high showed a decrease in the DWI signal in 
the tumour. However, no drop in signal was seen in tumours with a general 
contrast effect. However, in STIR combination DWI, a drop in the signal 
was observed when scanning was performed after contrast enhancement. 
The values of ADC calculated with MPG from b=0, 500, 1000 x 10-3 s/mm2 
in the three imaging techniques—non-fat suppression DWI, STIR-DWI and 
CHESS-DWI—using ten phantoms with Gd dissolved in physiological 
saline at concentrations of 0.0005–0.1 mmol are shown in Fig. 4. No 
changes in ADC were observed in non-fat suppression DWI or CHESS 
combination DWI up to a Gd density of 0.05 mmol, but ADC tended to 
decrease at Gd densities above this level. In addition, in STIR combination 
DWI, no changes in ADC were seen up to 0.008 mmol Gd, but the value 
tended to decrease above this density. The distribution of contrast medium 
level in the tumour described above is surrounded with a solid line in Fig. 4. 
In all imaging techniques, no changes in ADC were seen with contrast 




The present study was performed to determine whether the magnetic 
susceptibility of contrast medium alters the body-DWI signal and the value 
of ADC in various imaging techniques 
We used phantoms of different Gd density and performed analyses with 
three imaging sequences: non-fat suppression DWI, STIR combination 
DWI and CHESS combination DWI. 
Non-fat suppression DWI and CHESS combination DWI showed similar 
signal intensity curves for Gd density (Fig. 3). In addition, signal values of 
DWI did not change until a Gd density 0.005 mmol, but showed a tendency 
to decrease at densities above this level. This was regarded as an effect of 
magnetic susceptibility of the Gd contrast medium. The effect of 
susceptibility is dependent on the imaging parameters used. Therefore, in 
this study, no signal changes were observed up to a Gd density of 0.005 
mmol, but signal intensity may change at other Gd densities or with the use 
of other devices and/or parameters. 
It was suggested that the signal intensity of DWI would not change after 
contrast enhancement if optimal parameters were selected. Therefore, the 
detectability would not alter the tumour search ability after contrast 
enhancement if CHESS is used as the fat suppression method. However, 
for STIR combination DWI, the signal value dropped with increases in Gd 
density and was lower than in the other imaging techniques. This was 
regarded as due to the influence of T1 relaxation and low SNR caused by 
the use of STIR. Therefore, it was suggested that tumour detection is 
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decreased if STIR is used for fat suppression. Images using CHESS-DWI 
before and after contrast enhancement of meningioma on the brain are 
shown in Fig. 5. Signal intensity did not change after contrast enhancement. 
Images obtained using STIR-DWI before and after contrast enhancement 
on a brain tumour are shown in Fig. 6. A marked reduction in the signal 
was observed in the image after as compared with that before contrast 
enhancement. 
When ADC was used for tumour discrimination, it was not influenced by 
contrast medium density distributed over the tumour in any of the imaging 
techniques used in the present study (Fig. 4). Therefore, the ADC 
calculation was revised to ensure an equal effect of susceptibility for each b 
value of MPG. 
However, this experiment reviewed the influence only with regard to 
susceptibility of the contrast medium using a phantom. In references 14–16, 
it was reported that the ADC of tumour was reduced by increasing the 
concentration of contrast medium. Thus, blood vessel shrinkage by contrast 
medium and changes in blood viscosity were considered to affect ADC. 
However, it has been reported that contrast medium had no influence on 
ADC in mice (17). Therefore, further detailed studies including calculation 
of the precision of ADC and imaging parameters are necessary. 
 
Conclusions 
The effects of the magnetic susceptibility of contrast medium on the signal 
intensity and ADC of body-DWI after contrast enhancement were 
examined. Phantoms of different Gd density were examined using three 
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different imaging techniques: i.e., non-fat suppression DWI, STIR 
combination DWI and CHESS combination DWI. 
Considering Gd density to be distributed over the entire tumour, ADC 
showed no change after contrast enhancement for all imaging techniques. 
The signal intensity did not change in non-fat suppression and CHESS 
combination DWI, but decreased on STIR after contrast enhancement. 
However, the present study examined only the effects of magnetic 
susceptibility of contrast medium. Further detailed studies regarding the 
use of contrast medium in human subjects are required. 
 
References 
1. Takahara T, Imai Y, Yamashita T, et al. Diffusion weighted whole body 
imaging with background body signal suppression (DWIBS): technical 
improvement using free breathing, STIR and high resolution 3D display. 
Radiat Med (22), 275-282, 2004. 
2. Nasu K, Kuroki Y, Nawano S, et al. Hepatic mrtastases: Diffusion 
weighted sensitivity-encoding versus SPIO-enhanced MR imaging. 
Radiology(239), 122-130, 2006. 
3.Moteki T,Ishizuka H. Diffusion-weighted EPI of cystic ovarian lesions: 
evaluation of cystic contents using apparent diffusion coefficients. J Magn 
Reson Imaging(12), 1014-1019, 2000. 
4.Moteki T, Horikoshi H, Endo K. Diffusion coefficient and signal intensity 
in endometrial and other pelvic cysts. Magn Reson Imaging (20), 463-470, 
2002. 
5.Sato C, Naganawa S, Nakamura T, et al. Differentiation of noncancerous 
 10
tissue and cancer lesions by apparent diffusion coefficient values in 
transition and peripheral zones of the prostate. J.Magn.Reson.Imaging (21), 
258-262, 2005. 
6.Shimofusa R, Fujimoto H, Akamoto H,et al. Diffusion-weighted imaging 
of prostate cancer. J Compt Assist Tomogr(29), 149-153, 2005. 
7.Naganawa S, Sato C, Kumada H, et al. Apparent diffusion coefficient in 
cervical cancer of the uterus: comparison with the normal uterine cervix. 
Eur Radiol(15), 71-78, 2005. 
8.K Hosseinzadeh, SD Schwarz. Endorectal diffusion-weighted imaging in 
prostate cancer to differentiate malignant and benign peripheral zone tissue; 
J.Magn.Reson.Imaging (20), 654-661, 2004. 
9. Naganawa S, Kawai H, Fukatsu H, et al. Difusion-weighted imaging of 
the liver: Technical challenges and prospects for the future; Magnetic 
Resonance in Medical Sciences(4) , 175-186, 2005. 
10.MD Pickles, P Gibbs, M Sreenivas, et al. Diffusion-weighted imaging of 
normal and malignant prostate tissue at 3T; J.Magn.Reson.Imaging (23), 
130-134, 2006. 
11.M Koinuma, I Ohashi, K Hanafusa, et al. Apparent diffusion coefficient 
measurements with diffusion-weighted magnetic resonance imaging for 
evaluation of hepatic fibrosis; J.Magn.Reson.Imaging (22), 80-85, 2005. 
12.Sun XJ, Quan XY, Huang FH, et al. Quantitative evaluation of 
diffusion-weighted magnetic resonance imaging of focal hepatic lesions; 
World J Gastroenterol, 11(41), 6535-6537, (2005). 
13.T Yoshikawa, H Kawamitsu, DG Mitchell, et al. ADC measurement of 
abdominal organs and lesions using parallel imaging technique; AJR(187), 
 11
1522-1530, (2006). 
14. Dose MD, Zhong J, Gore JC. In vivo measurement of ADC change due 
to intravasucular susceptibility variation. Magn Reson Med (41), 236-240, 
1999. 
15. Zhong J, Kennan RP, Fulbringht RK, et al. Quantification of 
intravascular and extravascular contributions to bold effects induced by 
alteration in oxygenation or intravascular contrast agents. Magn Reson 
Med (40), 526-536, 1998 
16.Yamada K, Kubita H, Kizu O, et al.. Effect of Intravenous 
Gadolinium-DTPA on Diffusion Weighted images: Stroke 1799-1802, 2002 
17.Chen G, Jespersen SN, Pederson M, et al..Intravenous administration of 
Gd-DTPA prior to DWI dose not affect the apparent diffuision constant. 




Fig.1 T1-weighted image and DWI of the nine phantoms that dissolved in a 
physiology solution of salt from 0.0005 to 0.1mmol in Gd-DTPA into a 
water tank. 
Fig.2  Quantity of Gd distribution before and after contrasting of 20 
meningiomas and 20 metastases to brain. the quantity of Gd-DTPA 
distribution to a tumor by the contrast media dosage estimated it with 
0.001-0.005mmol. 
Fig.3  The pixel value of ten phantoms that dissolved in a physiology 
solution of salt from 0.0005 to 0.1mmol in Gd-DTPA were perforemed on 
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DWI non-fat suppression, STIR combination DWI and CHESS 
combination DWI in b=1000 x10-3 s/mm2 in MPG. Both non-fat 
suppression DWI and CHESS combination DWI showed similar signal 
intensity for Gd density. And a signal value did not show a change to Gd 
density 0.005mmol but showed a tendency to fall when density rose more 
than it. 
Fig.4   A value of ADC which calculated MPG from b=0,500, 1000 x10-3 
s/mm2 in three imaging technique of DWI that non-fat suppression DWI, 
STIR-DWI and CHESS-DWI using ten phantoms who dissolved in a 
physiology solution of salt to 0.0005 to 0.1mmol. 
Fig.5   Images using CHESS-DWI before and after contrasting of 
meninngioma on the brain. Signal intensity understands that there is not a 
change at before and after contrasting. 
Fig.6   Images using STIR-DWI before and after contrasting on a brain 
tumor. A signal of image after contrasting is decrease conspicuously 
compare from one of before contrasting. 
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